Fei Jie

804 total citations
31 papers, 605 citations indexed

About

Fei Jie is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Fei Jie has authored 31 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Fei Jie's work include Breast Cancer Treatment Studies (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Digital Radiography and Breast Imaging (4 papers). Fei Jie is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Digital Radiography and Breast Imaging (4 papers). Fei Jie collaborates with scholars based in China, United States and Spain. Fei Jie's co-authors include Ran Liu, Weixing Chen, Haoran Liu, Cuiyan Li, Haibo Ouyang, Liyun Cao, Anne Keating, Joyce Steinberg, Chunxiao Cui and Xiaohui Su and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Water Research.

In The Last Decade

Fei Jie

29 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Jie China 14 162 119 104 104 89 31 605
Tianxu Fang China 13 194 1.2× 80 0.7× 75 0.7× 61 0.6× 88 1.0× 18 628
Yikun Yang China 13 124 0.8× 40 0.3× 86 0.8× 91 0.9× 138 1.6× 35 571
Sanja Dimitrijevic Serbia 9 142 0.9× 81 0.7× 19 0.2× 128 1.2× 28 0.3× 14 596
Marco Soster Italy 11 201 1.2× 82 0.7× 55 0.5× 73 0.7× 81 0.9× 15 597
Yu Qin China 17 398 2.5× 159 1.3× 48 0.5× 131 1.3× 94 1.1× 31 1.1k
Marla Pyle United States 17 377 2.3× 77 0.6× 19 0.2× 234 2.3× 67 0.8× 32 1.1k
Irene Kee Singapore 11 120 0.7× 34 0.3× 33 0.3× 46 0.4× 50 0.6× 16 551
Kexin Shi China 10 144 0.9× 75 0.6× 14 0.1× 37 0.4× 52 0.6× 24 491
Ramamurthy Gopalakrishnan United States 13 248 1.5× 41 0.3× 20 0.2× 62 0.6× 20 0.2× 16 531
Guojin Zhang China 13 134 0.8× 73 0.6× 9 0.1× 78 0.8× 83 0.9× 60 799

Countries citing papers authored by Fei Jie

Since Specialization
Citations

This map shows the geographic impact of Fei Jie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Jie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Jie more than expected).

Fields of papers citing papers by Fei Jie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Jie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Jie. The network helps show where Fei Jie may publish in the future.

Co-authorship network of co-authors of Fei Jie

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Jie. A scholar is included among the top collaborators of Fei Jie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Jie. Fei Jie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bartlett, Nancy L., Uwe Hahn, Won Seog Kim, et al.. (2025). Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology. 43(9). 1061–1072. 7 indexed citations
3.
Zhang, Yan, Shuzhi Zhang, Gang Gong, et al.. (2025). Impact of natural and socio-economic factors on varicella incidence in children in Shanghai, 2013-2022. Frontiers in Public Health. 13. 1565717–1565717. 1 indexed citations
4.
Zhu, Zheng, et al.. (2025). Sonar image denoising based on Noise2Void self-supervised learning. Remote Sensing Letters. 16(5). 560–571. 1 indexed citations
5.
Hua, Hui, et al.. (2024). Prediction of Disease-Free Survival in Breast Cancer using Deep Learning with Ultrasound and Mammography: A Multicenter Study. Clinical Breast Cancer. 24(3). 215–226. 5 indexed citations
6.
Kim, Jeong‐Ah, Uwe Hahn, Won-Seog Kim, et al.. (2024). Brentuximab vedotin in combination with lenalidomide and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma: Results from the phase 3 ECHELON-3 study.. Journal of Clinical Oncology. 42(17_suppl). LBA7005–LBA7005. 3 indexed citations
7.
Zhang, Yingjie, Fei Jie, Xuezhi Yu, et al.. (2024). Investigation of Antibody Tolerance in Methanol for Analytical Purposes: Methanol Effect Patterns and Molecular Mechanisms. Advanced Science. 11(31). e2402050–e2402050. 5 indexed citations
8.
Jie, Fei, et al.. (2024). A two-center study of a combined nomogram based on mammography and MRI to predict ALN metastasis in breast cancer. Magnetic Resonance Imaging. 110. 128–137. 3 indexed citations
10.
Bai, Yuchen, Fei Jie, Leina Dou, et al.. (2022). Minimum Distance Between Two Epitopes in Sandwich Immunoassays for Small Molecules. Analytical Chemistry. 94(51). 17843–17852. 12 indexed citations
11.
Su, Xiaohui, Qing Lin, Chunxiao Cui, Fei Jie, & Lili Li. (2018). Comparison of diagnostic accuracy of digital breast tomosynthesis, digital mammography, and ultrasonography for the non-calcified ductal carcinoma in situ of the breast. Zhonghua fangshexian yixue zazhi. 52(1). 15–19. 1 indexed citations
12.
Yu, Helena A., Alexander I. Spira, Leora Horn, et al.. (2017). A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non–small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations. Clinical Cancer Research. 23(24). 7467–7473. 23 indexed citations
13.
Jie, Fei, et al.. (2016). Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery. Journal of Controlled Release. 265. 113–119. 115 indexed citations
14.
Mateo, Joaquı́n, David Olmos, Herlinde Dumez, et al.. (2016). A first in man, dose-finding study of the mTORC1/mTORC2 inhibitor OSI-027 in patients with advanced solid malignancies. British Journal of Cancer. 114(8). 889–896. 48 indexed citations
15.
Jie, Fei & Ran Liu. (2016). Drug-laden 3D biodegradable label using QR code for anti-counterfeiting of drugs. Materials Science and Engineering C. 63. 657–662. 40 indexed citations
16.
Su, Xiaohui, Qing Lin, Chunxiao Cui, et al.. (2016). Non-calcified ductal carcinoma in situ of the breast: comparison of diagnostic accuracy of digital breast tomosynthesis, digital mammography, and ultrasonography. Breast Cancer. 24(4). 562–570. 26 indexed citations
17.
Clemens, Michael, Oleg Gladkov, Elaina M. Gartner, et al.. (2014). Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer. Breast Cancer Research and Treatment. 149(1). 171–179. 67 indexed citations
18.
Li, Cuiyan, Haibo Ouyang, Jianfeng Huang, et al.. (2014). Synthesis and visible-light photocatalytic activity of SiC/SiO2 nanochain heterojunctions. Materials Letters. 122. 125–128. 20 indexed citations
19.
Mateo, Joaquı́n, Patrick Schöffski, David Olmos, et al.. (2013). Abstract B187: Pharmacodynamics of OSI-027, a dual mTORC1/mTORC2 inhibitor, in tumor and surrogate tissues: Results from the expansion phase of a first-in-man study.. Molecular Cancer Therapeutics. 12(11_Supplement). B187–B187. 1 indexed citations
20.
Ouyang, Haibo, Jianfeng Huang, Xierong Zeng, et al.. (2013). Visible-light photocatalytic activity of SiC hollow spheres prepared by a vapor–solid reaction of carbon spheres and silicon monoxide. Ceramics International. 40(2). 2619–2625. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026